ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.188,34
0,00%
S&P 500
5.214,08
0,00%
US Dollar vs BRL
5,12566
-0,32%
Bitcoin
63.272,77
0,36%
Brent Oil
84,065
0,14%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Durect Corp (DRRX)

  7. Durect Corp (DRRX) Notícias

DRRX

Durect (DRRX)

Durect Corp
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:DRRX
DataHoraFonteTítuloCódigoCompanhia
07/05/202417:30PR Newswire (US)DURECT Corporation to Announce First Quarter 2024 Financial Results and Provide a Business UpdateNASDAQ:DRRXDurect Corp
30/04/202408:00PR Newswire (US)DURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in Alcohol-Associated HepatitisNASDAQ:DRRXDurect Corp
27/03/202417:01PR Newswire (US)DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:DRRXDurect Corp
20/03/202417:30PR Newswire (US)DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business UpdateNASDAQ:DRRXDurect Corp
04/03/202413:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRRXDurect Corp
04/03/202409:00PR Newswire (US)DURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZET® Product Line in U.S. and CanadaNASDAQ:DRRXDurect Corp
14/02/202418:16Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:DRRXDurect Corp
07/02/202420:48PR Newswire (US)DURECT Corporation to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:DRRXDurect Corp
13/11/202318:05PR Newswire (US)DURECT Corporation Reports Third Quarter 2023 Financial Results and Business UpdateNASDAQ:DRRXDurect Corp
09/11/202318:30PR Newswire (US)DURECT Corporation to Announce Third Quarter 2023 Financial Results and Provide a Business UpdateNASDAQ:DRRXDurect Corp
07/11/202318:01PR Newswire (US)DURECT Corporation Announces Topline Results from Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis with Promising Effect on MortalityNASDAQ:DRRXDurect Corp
07/09/202308:00PR Newswire (US)DURECT Corporation Announces Last Patient Last Visit in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated HepatitisNASDAQ:DRRXDurect Corp
31/08/202317:30PR Newswire (US)DURECT Corporation Announces Presentations in Upcoming Investor ConferencesNASDAQ:DRRXDurect Corp
10/08/202317:21Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DRRXDurect Corp
10/08/202317:18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DRRXDurect Corp
09/08/202317:05PR Newswire (US)DURECT Corporation Reports Second Quarter 2023 Financial Results and Business UpdateNASDAQ:DRRXDurect Corp
03/08/202317:30PR Newswire (US)DURECT Corporation to Announce Second Quarter 2023 Financial Results and Provide a Business UpdateNASDAQ:DRRXDurect Corp
21/07/202311:38Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:DRRXDurect Corp
20/07/202309:00PR Newswire (US)DURECT Corporation Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesNASDAQ:DRRXDurect Corp
23/06/202318:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRRXDurect Corp
22/06/202317:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DRRXDurect Corp
07/06/202307:00PR Newswire (US)DURECT Completes Enrollment in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated HepatitisNASDAQ:DRRXDurect Corp
08/05/202317:05PR Newswire (US)DURECT Corporation Reports First Quarter 2023 Financial Results and Business UpdateNASDAQ:DRRXDurect Corp
01/05/202320:03PR Newswire (US)DURECT Corporation to Announce First Quarter 2023 Financial Results and Provide Business Update on May 8NASDAQ:DRRXDurect Corp
27/04/202318:11PR Newswire (US)DURECT Corporation to Host KOL Event on Alcohol-Associated HepatitisNASDAQ:DRRXDurect Corp
27/04/202317:52Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:DRRXDurect Corp
27/04/202317:43Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:DRRXDurect Corp
27/04/202317:33Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:DRRXDurect Corp
25/04/202319:45PR Newswire (US)DURECT Corporation to Participate in Fireside Chat at the H.C. Wainwright BioConnect Investor ConferenceNASDAQ:DRRXDurect Corp
10/04/202307:00PR Newswire (US)DURECT Announces Peer-Reviewed Article Accepted for Publication with Additional Data from Previously Completed Phase 2a Study of Larsucosterol in Alcohol-Associated HepatitisNASDAQ:DRRXDurect Corp
 Apresentando as notícias mais relevantes sobre:NASDAQ:DRRX

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
IFCM3
Infracommerce Caxaas ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
VVEO3
CM Hospitalar ON
BOV
PRIO3
PETRORIO ON
BOV
HBRE3
HBR Realty Empreendiment... ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
TELB4
TELEBRAS PN
BOV
LUPA3
LUPATECH ON
BOV
COGN3
COGNA ON
BOV
TCSA3
TECNISA ON
BOV
CMIN3
CSN Mineracao S.A ON
BOV
RNEW4
RENOVA PN
BOV
SHOW3
TIME FOR FUN ON
BOV
CASH3
Meliuz S.A ON
BOV
PDTC3
Padtec ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados